Kames Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$29.6M Sell
283,359
-51,003
-15% -$5.37M 0.87% 42
2014
Q3
$35.6M Buy
334,362
+13,809
+4% +$1.43M 1.11% 36
2014
Q2
$33.5M Sell
320,553
-55,512
-15% -$5.61M 1.07% 35
2014
Q1
$36.9M Sell
376,065
-26,521
-7% -$2.46M 1.17% 33
2013
Q4
$36.9M Sell
402,586
-45,987
-10% -$4.24M 1.23% 29
2013
Q3
$38.9M Sell
448,573
-83,834
-16% -$7.52M 1.2% 25
2013
Q2
$45.7M Buy
+532,407
New +$45.2M 1.61% 20

Other funds holding JNJ

Kames Capital Management's JNJ Position: Q4 2014 in Review

Kames Capital Management reduced its Johnson & Johnson (JNJ) stake by 15% in Q4 2014, selling an estimated $5.37M and leaving 283,359 shares worth $29.6M. The position accounts for 0.87% of the portfolio, ranked #42.

Kames Capital Management first reported a position in JNJ in Q2 2013 and has held it in 7 quarters since. The position peaked at $45.7M in Q2 2013. 2,120 funds tracked by Wall St. Rank hold JNJ as of Q4 2014.

  • Kames Capital Management held 283,359 shares of Johnson & Johnson worth $29.6M as of Q4 2014.
  • Kames Capital Management sold 51,003 Johnson & Johnson shares in Q4 2014, an estimated $5.37M.
  • Johnson & Johnson made up 0.87% of Kames Capital Management's portfolio in Q4 2014, its #42 holding.
  • Kames Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 7 quarters since.
  • Kames Capital Management's Johnson & Johnson position peaked at $45.7M in Q2 2013.
  • 2,120 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2014.

Based on Kames Capital Management's 13F filing for Q4 2014, filed 3 Feb 2015.